• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [16962 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2017     Center for Evidence-based Practice (CEP) High-dose Vitamin C for treatment of sepsis
2017     HAYES, Inc. Roux-en-Y gastric bypass for treatment of Type II Diabetes: a review of reviews
2017     Center for Evidence-based Practice (CEP) Peer specialists in crisis response centers
2017     HAYES, Inc. Surgical treatment for lymphedema: a review of reviews
2017     Center for Evidence-based Practice (CEP) APSO vs. SOAP structure for progress notes
2017     NIHR Health Technology Assessment programme Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model
2017     HAYES, Inc. Comparative effectiveness review of dry needling for mechanical neck and/or trapezius muscle pain in adults
2017     Center for Evidence-based Practice (CEP) Oral antibiotics for secondary prophylaxis following two-stage revision surgery for prosthetic joint infection
2017     NIHR Health Technology Assessment programme Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis
2017     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation
2017     Center for Evidence-based Practice (CEP) Association of hats with risk of SIDS in newborns
2017     NIHR Health Technology Assessment programme Observational study to estimate the changes in the effectiveness of bacillus Calmette Guerin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK
2017     Center for Evidence-based Practice (CEP) Family presence during resuscitation
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of exome sequencing for diagnosed dismorphic syndromes, with or without intellectual disabilities. Literature review
2017     NIHR Health Technology Assessment programme Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines
2017     Center for Evidence-based Practice (CEP) Productivity and access measures for primary care
2017     Andalusian Health Technology Assessment Area (AETSA) Assessment of efficacy, effectiveness and safety of transcranial doppler ultrasonography in acute ischaemic stroke
2017     NIHR Health Technology Assessment programme Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation
2017     Center for Evidence-based Practice (CEP) Intravenous iron for patients with anemia
2017     Andalusian Health Technology Assessment Area (AETSA) CMV-specific T-cell immunity in kidney transplantation. Monitoring the CMV-specific T-cell response: pre and post-transplant
2017     NIHR Health Technology Assessment programme Clinical and cost-effectiveness of beta interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation
2017     Center for Evidence-based Practice (CEP) Mortality review
2017     NIHR Public Health Research (PHR) programme Health impacts of the M74 urban motorway extension: a mixed-method natural experimental study
2017     Center for Evidence-based Practice (CEP) Pre-procedural fasting for inpatients undergoing interventional radiology or cardiac procedures not requiring general anesthesia
2017     NIHR Health Technology Assessment programme Effects of antenatal diet and physical activity on maternal and fetal outcomes: individual patient data meta-analysis and health economic evaluation
2017     HAYES, Inc. Endovenous mechanochemical ablation (MOCA) (ClariVein infusion catheter, nonthermal vein ablation system; Vascular Insights LLC) for treatment of varicose veins
2017     Center for Evidence-based Practice (CEP) Evaluation and management of post-discharge fever in prosthetic joint replacement patients
2017     HAYES, Inc. Extreme Lateral Interbody Fusion (XLIF; NuVasive Inc.) for treatment of degenerative spinal disorders
2017     HAYES, Inc. Implantable cardiac loop recorders for detection of atrial fibrillation following cryptogenic stroke
2017     HAYES, Inc. Laminotomy for lumbar spinal stenosis
2017     Center for Evidence-based Practice (CEP) Support for 'second victims' in the acute care setting
2017     NIHR Health Services and Delivery Research programme Interventions to improve contact tracing for tuberculosis in specific groups and in wider populations: an evidence synthesis
2017     HAYES, Inc. Neodymium-doped yttrium aluminium garnet laser treatment for onychomycosis
2017     Center for Evidence-based Practice (CEP) Protocols for discontinuing the use of 1:1 patient sitters in the acute care setting
2017     NIHR Health Technology Assessment programme Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost-effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
2017     HAYES, Inc. Open sacroiliac joint fusion for unspecified sacroiliac joint dysfunction
2017     NIHR Health Technology Assessment programme Randomised controlled trial and economic analysis of an internet-based weight management programme: POWeR+ (Positive Online Weight Reduction)
2017     HAYES, Inc. SurgiMend (Integra Life Sciences) for postmastectomy breast reconstruction
2017     NIHR Health Services and Delivery Research programme Functionality and feedback: a realist synthesis of the collation, interpretation and utilisation of patient-reported outcome measures data to improve patient care
2017     HAYES, Inc. The clinical utility of navigated transcranial magnetic stimulation for presurgical planning for brain tumors
2017     NIHR Health Technology Assessment programme Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility study
2017     Health Quality Ontario (HQO) Long-term continuous ambulatory ECG monitors and external cardiac loop recorders for cardiac arrhythmia: a health technology assessment
2017     NIHR Health Services and Delivery Research programme Better guidelines for better care: accounting for multimorbidity in clinical guidelines structured examination of exemplar guidelines and health economic modelling
2017     Andalusian Health Technology Assessment Area (AETSA) Hip arthroscopy. Appropriateness criteria
2017     NIHR Health Technology Assessment programme The clinical effectiveness of individual behaviour change interventions to reduce risky sexual behaviour after a negative human immunodeficiency virus test in men who have sex with men: systematic and realist reviews and intervention development
2017     NIHR Health Services and Delivery Research programme NHS top managers, knowledge exchange and leadership: the early development of Academic Health Science Networks a mixed-methods study
2017     Andalusian Health Technology Assessment Area (AETSA) Utility of pulmonary metastases resection for colorectal cancer
2017     NIHR Health Services and Delivery Research programme Factors that influence variation in clinical decision-making about thrombolysis in the treatment of acute ischaemic stroke: results of a discrete choice experiment
2017     NIHR Health Services and Delivery Research programme Improving the capabilities of NHS organisations to use evidence: a qualitative study of redesign projects in Clinical Commissioning Groups
2017     Andalusian Health Technology Assessment Area (AETSA) Non invasive fetal lung maturity test
2017     NIHR Health Technology Assessment programme Autologous chondrocyte implantation in the knee: systematic review and economic evaluation
2017     NIHR Health Services and Delivery Research programme Community hospitals and their services in the NHS: identifying transferable learning from international developments - scoping review, systematic review, country reports and case studies
2017     NIHR Health Services and Delivery Research programme Effects of a demand-led evidence briefing service on the uptake and use of research evidence by commissioners of health services: a controlled before-and-after study
2017     NIHR Health Services and Delivery Research programme A realist process evaluation of robot-assisted surgery: integration into routine practice and impacts on communication, collaboration and decision-making
2017     Andalusian Health Technology Assessment Area (AETSA) Intra-abdominal vagal nerve blockade and malabsortive devices for severe obesity.
2017     Adelaide Health Technology Assessment (AHTA) Serious adverse events associated with HPV vaccination
2017     NIHR Health Technology Assessment programme Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trial
2017     NIHR Health Services and Delivery Research programme The Community IntraVenous Antibiotic Study (CIVAS): a mixed-methods evaluation of patient preferences for and cost-effectiveness of different service models for delivering outpatient parenteral antimicrobial therapy
2017     NIHR Health Services and Delivery Research programme Seclusion and Psychiatric Intensive Care Evaluation Study (SPICES): combined qualitative and quantitative approaches to the uses and outcomes of coercive practices in mental health services
2017     Andalusian Health Technology Assessment Area (AETSA) Hip arthroplasty in patients with osteoarthritis
2017     NIHR Health Services and Delivery Research programme Elective hospital admissions: secondary data analysis and modelling with an emphasis on policies to moderate growth
2017     NIHR Health Services and Delivery Research programme Decommissioning health care: identifying best practice through primary and secondary research a prospective mixed-methods study
2017     Andalusian Health Technology Assessment Area (AETSA) Direct acting antivirals for the chronic hepatitis C infection. Relative assessment of efficacy and safety. Executive summary
2017     NIHR Health Services and Delivery Research programme Critical time Intervention for Severely mentally ill Prisoners (CrISP): a randomised controlled trial
2017     NIHR Health Services and Delivery Research programme Evaluating the effectiveness and cost-effectiveness of British Sign Language Improving Access to Psychological Therapies: an exploratory study
2017     Center for Evidence-based Practice (CEP) Epidemiology of spectator injuries at baseball games
2017     Andalusian Health Technology Assessment Area (AETSA) Multitarget stool DNA testing for colorectal cancer screening.
2017     NIHR Health Services and Delivery Research programme n evaluation of the effectiveness of annual health checks and quality of health care for adults with intellectual disability: an observational study using a primary care database
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneous aortic valve replacement (TAVI) in Austria. Part 2: Data analysis]
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Plerixafor as first-line choice for stem cell mobilization in non-Hodgkin's lymphoma and multiple myeloma patients
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Social return on investment: outcomes, methods, and economic parameters
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of the LEADER study on liraglutide - rapid report]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Nivolumab (Opdivo®) for metastatic DNA mismatch repair-deficient (dMMR) or microsatellite instability-high (MSI-H) colorectal cancer (CRC)
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Baricitinib (rheumatoid arthritis) - addendum to commission A17-14]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Durvalumab (Imfinzi™) for the treatment of patients with stage III non-small-cell lung cancer after prior chemoradiotherapy
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Dolutegravir (HIV infection) - addendum to commission A17-11]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Perinatal care at the threshold of viability; Part I: Systematic analysis of outcomes and resource needs for neonatal intensive care units to inform healthcare planning
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ultrasound-guided high-intensity focused ultrasound for malignant neoplasms of the pancreas – addendum to commission H16-02C]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Perinatal Care at the threshold of viability Part II: Decision-making at the threshold of viability and ethical challenges at Neonatal Intensive Care Units (NICUs)
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Blinatumomab (acute lymphoblastic leukaemia) - assessment according to §35a (para. 1., sentence 10) Social Code Book V (expiry of the decision)]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (melanoma) - benefit assessment according to §35a Social Code Book V (expiry of the decision)]
2017     NIHR Health Technology Assessment programme Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation
2017     NIHR Health Technology Assessment programme The assessment and appraisal of regenerative medicines and cell therapy products: an exploration of methods for review, economic evaluation and appraisal
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nusinersen (spinal muscular atrophy) - assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2017     NIHR Health Services and Delivery Research programme Measuring harm and informing quality improvement in the Welsh NHS: the longitudinal Welsh national adverse events study
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cerliponase alfa (neuronal ceroid lipofuscinosis) - assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Psychotherapy - concepts, effect factors and a comparison of legal regulations in three German speaking countries]
2017     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nivolumab (urothelial carcinoma) - benefit assessment according to §35a Social Code Book V]
2017     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling
2017     NIHR Public Health Research (PHR) programme The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations
2017     NIHR Health Technology Assessment programme Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Palbociclib (Ibrance®) in combination with fulvestrant for the treatment of hormone-receptor-positive, HER2-negative advanced or metastatic breast cancer
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Ribociclib in combination with letrozole for the first-line therapy of HR-positive, HER2-negative recurrent or metastatic breast cancer
2017     Technology Assessment Unit of the McGill University Health Centre (MUHC) Use of extracorporeal membrane oxygenation for cardiac life support in adult subjects
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Neratinib for the treatment of patients with HER2-positive breast cancer after trastuzumab-based adjuvant therapy
2017     Belgian Health Care Knowledge Centre (KCE) Static automated external defibrillators for opportunistic use by bystanders
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Olaparib (Lynparza®) in patients with BRCA-mutated metastatic breast cancer
2017     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Abemaciclib (Verzenio®) in combination with fulvestrant for treatment of HR-positive, HER2-negative advanced breast cancer (ABC)
2017     HAYES, Inc. Antibiotic-impregnated bone cement for knee arthroplasty
2017     HAYES, Inc. Capsule endoscopy for the diagnosis of small bowel Crohn's disease